Novartis AG risk profile
25 Normal where most of the sector sits
Measured 1 September 2026 from NVS's filed statements. Recomputed nightly.
25 (Normal), driven by Competitive position at 32, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 20 | Normal | Stable | One-year price volatility — 21.9% |
| Operating pressure | 19 | Contained | Stable | Costs outgrowing revenue — -4.6 percentage points |
| Cash conversion | 24 | Normal | Stable | Cash conversion — 1.37x |
| Leverage and coverage | 20 | Normal | Stable | Current ratio — 1.12x |
| Competitive position | 32 | Normal | Stable | Revenue-growth gap against peers — +1.0 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.